Essential Thrombocythemia (ET)

DBCOND0048758Hemic and Lymphatic DiseasesNeoplasms

Essential Thrombocythemia (ET) is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Thrombocythemia, Essential · Essential Thrombocythemia · Thrombocythemia, Hemorrhagic · Essential Thrombocythaemia · Essential Thrombocytosis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0021427ICD-10D47.3SNOMED CT109994006MedDRA10015493UMLSC0040028

What you can answer from here — as of November 01, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
199Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Essential Thrombocythemia (ET) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In